Home Page – 6th EORTC QOL Conference
The 6th EORTC Quality of Life in Cancer Clinical Trials Conference will take place on the 12th and 13th of May 2025, in Barcelona (Spain).
Related Articles
Important New Results From EORTC Presented At ESTRO 2025
At this year’s ESTRO congress, held in Vienna from 2 May to 6 May, EORTC researchers once again presented important results.
Young & Early Career Investigator – EORTC
EORTC is dedicated to fostering the development of young doctors working in the EORTC network in clinical and translational cancer research. We want to help
Defining The Role Of Pragmatic Clinical Trials
The outcomes of the multi stakeholder workshop on Pragmatic Clinical Trials are today published in Lancet Oncology.
Important New Results From EORTC Presented At ESTRO 2025
At this year’s ESTRO congress, held in Vienna from 2 May to 6 May, EORTC researchers once again presented important results.
Home Page – 6th EORTC QOL Conference
The 6th EORTC Quality of Life in Cancer Clinical Trials Conference will take place on the 12th and 13th of May 2025, in Barcelona (Spain).
Less red tape and lower costs: How the UK-EU political reset can support cancer research progress worldwide – Cancer Research UK – Cancer News
We reflect on how the UK and EU could grasp opportunities for scientific cooperation to promote health and wealth across the continent
EORTC Quality Of Life Group Unveils Flexible, Future-focused Strategy For Patient-reported Outcome Assessment In Cancer Care – EORTC
A new publication in EJC outlines EORTC’s strategy for the measurement of health-related quality of life and patient-reported outcomes in oncology.
The EORTC-2387 SPRINT study has been activated
The EORTC-2387 SPRINT study is the first pan-European Trial within Cohorts (TwiCs) targeting patients with oligometastatic disease.
Practice-Changing Studies – EORTC
Since 1962, EORTC has enrolled around 220,000 patients in clinical trials across tumour types.​ Many of these studies have changed best practice ​for treating
EMA-EORTC Workshop On Patient Reported Outcomes And Quality Of Life Data In Regulatory Decision-making
A new article by Pe, Voltz et al. in The Lancet Oncology summarises highlights from a joint EMA-EORTC workshop held on 29 February 2024